AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Chemring Group PLC

Net Asset Value Mar 1, 2019

5264_rns_2019-03-01_f777fb87-2800-453f-add8-6b0e1e415b26.html

Net Asset Value

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6168R

Chemring Group PLC

01 March 2019

FOR immediate RELEASE                                                                                           1 March 2019

CHEMRING GROUP PLC

VOTING RIGHTS AND CAPITAL

In conformity with the FCA's Disclosure and Transparency Rule 5.6.1R, Chemring Group PLC notifies the following:

As at the close of 28 February 2019, Chemring Group PLC's capital consisted of 281,795,638 1p ordinary shares with voting rights and 62,500 cumulative preference shares with no voting rights, save in specified limited circumstances. Chemring Group PLC holds 1,788,710 ordinary shares in treasury.  Therefore, the total number of ordinary shares with voting rights in Chemring Group PLC is 280,006,928.

The above figure (280,006,928) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Chemring Group PLC under the FCA's Disclosure and Transparency Rules.

For further information:

Georgia Bailey - Assistant Company Secretary, Chemring Group PLC - 01794 833901

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

TVRFMGGFMMLGLZM

Talk to a Data Expert

Have a question? We'll get back to you promptly.